These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8134232)

  • 21. Effectiveness of a seventh grade school entry vaccination requirement--statewide and Orange County, Florida, 1997-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Sep; 47(34):711-5. PubMed ID: 9746399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS; Nokes DJ
    Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-course therapy for tuberculosis in infants and children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ; 1994 Apr; 150(8):1233-9. PubMed ID: 8162546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization of adolescents.
    Averhoff FM; Williams WW; Hadler SC
    Am Fam Physician; 1997 Jan; 55(1):159-67. PubMed ID: 9012275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How do physicians immunize their own children? Differences among pediatricians and nonpediatricians.
    Posfay-Barbe KM; Heininger U; Aebi C; Desgrandchamps D; Vaudaux B; Siegrist CA
    Pediatrics; 2005 Nov; 116(5):e623-33. PubMed ID: 16263976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moving the second dose of measles-mumps-rubella vaccine to school entry: implications for control of rubella.
    Heath TC; Burgess MA; Forrest JM
    Commun Dis Intell; 1998 Aug; 22(8):157-8. PubMed ID: 9735550
    [No Abstract]   [Full Text] [Related]  

  • 27. The sequence of vaccinations and increased female mortality after high-titre measles vaccine: trials from rural Sudan and Kinshasa.
    Aaby P; Ibrahim SA; Libman MD; Jensen H
    Vaccine; 2006 Apr; 24(15):2764-71. PubMed ID: 16457909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress toward measles elimination--Japan, 1999-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Sep; 57(38):1049-52. PubMed ID: 18818586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic studies of specific mucosal and systemic immune responses in Mexican school children after booster aerosol or subcutaneous immunization with measles vaccine.
    Bellanti JA; Zeligs BJ; Mendez-Inocencio J; García-Garcia ML; Islas-Romero R; Omidvar B; Omidvar J; Kim G; Fernandez De Castro J; Sepulveda Amor J; Walls L; Bellini WJ; Valdespino-Gomez JL
    Vaccine; 2004 Mar; 22(9-10):1214-20. PubMed ID: 15003650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recommended childhood immunization schedule-United States, January-December 1999. American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 1999 Jan; 103(1):182-5. PubMed ID: 9917462
    [No Abstract]   [Full Text] [Related]  

  • 31. American Academy of Pediatrics. Committee on Infectious Diseases. Varicella vaccine update.
    Pediatrics; 2000 Jan; 105(1 Pt 1):136-41. PubMed ID: 10617719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Child vaccination, part 2: childhood vaccination procedures.
    Zimmerman RK; Burns IT
    J Fam Pract; 2000 Sep; 49(9 Suppl):S34-9; quiz S40. PubMed ID: 11032191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time interval of measles vaccination in patients with Kawasaki disease treated with additional intravenous immune globulin.
    Miura M; Katada Y; Ishihara J
    Eur J Pediatr; 2004 Jan; 163(1):25-9. PubMed ID: 14624356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress toward implementation of a second-dose measles immunization requirement for all schoolchildren in the United States.
    Kolasa MS; Klemperer-Johnson S; Papania MJ
    J Infect Dis; 2004 May; 189 Suppl 1():S98-103. PubMed ID: 15106097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
    Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
    Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.
    Pickering LK; Baker CJ; Freed GL; Gall SA; Grogg SE; Poland GA; Rodewald LE; Schaffner W; Stinchfield P; Tan L; Zimmerman RK; Orenstein WA;
    Clin Infect Dis; 2009 Sep; 49(6):817-40. PubMed ID: 19659433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intravenous immunoglobulin therapy].
    Mouthon L
    Rev Prat; 2005 May; 55(10):1049-56. PubMed ID: 16097244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life.
    Nair N; Gans H; Lew-Yasukawa L; Long-Wagar AC; Arvin A; Griffin DE
    J Infect Dis; 2007 Nov; 196(9):1339-45. PubMed ID: 17922398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
    Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H
    Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay.
    Hamkar R; Mahmoodi M; Nategh R; Jelyani KN; Eslami MB; Mohktari-Azad T
    East Mediterr Health J; 2006 Nov; 12(6):775-82. PubMed ID: 17333822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.